Comparing palliative treatment options for cholangiocarcinoma: photodynamic therapy vs. radiofrequency ablation

키워드

참고문헌 (64)

1. Krasinskas AM, "Cholangiocarcinoma", Surg Pathol Clin, 11, pp.403~429 (2018)
2. Blechacz B, "Clinical diagnosis and staging of cholangiocarcinoma", Nat Rev Gastroenterol Hepatol, 8, pp.512~522 (2011)
3. Bismuth H, "Management strategies in resection for hilar cholangiocarcinoma", Ann Surg, 215, pp.31~38 (1992)
4. Chung YE, "Staging of extrahepatic cholangiocarcinoma", Eur Radiol, 18, pp.2182~2195 (2008)
5. Rizvi S, "Cholangiocarcinoma : evolving concepts and therapeutic strategies", Nat Rev Clin Oncol, 15, pp.95~111 (2018)
6. Dumonceau JM, "Biliary stenting : indications, choice of stents and results. European Society of Gastrointestinal Endoscopy(ESGE)clinical guideline", Endoscopy, 44, pp.277~298 (2012)
7. Liberato MJ, "Endoscopic stenting for hilar cholangiocarcinoma : efficacy of unilateral and bilateral placement of plastic and metal stents in a retrospective review of 480 patients", BMC Gastroenterol, 12, pp.103~ (2012)
8. Sangchan A, "Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma : a randomized controlled trial", Gastrointest Endosc, 76, pp.93~99 (2012)
9. Larghi A, "Endoscopic radiofrequency biliary ablation treatment : a comprehensive review", Dig Endosc, 31, pp.245~255 (2019)
10. Steel A, "T1611 : the use of a novel endoscopically placed radiofrequency probe for the management of malignant bile duct obstruction", Gastrointest Endosc, 71, pp.PAB321~ (2010)
11. Figueroa-Barojas P, "Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer : a novel palliation technique", J Oncol, 2013, pp.910897~ (2013)
12. Sharaiha RZ, "Comparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictures : is there an added benefit?", Dig Dis Sci, 59, pp.3099~3102 (2014)
13. Yang J, "Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma : a randomized trial", Endoscopy, 50, pp.751~760 (2018)
14. Allison RR, "Cholangiocarcinoma : an emerging indication for photodynamic therapy", Photodiagnosis Photodyn Ther, 6, pp.84~92 (2009)
15. McCaughan JS Jr, "Photodynamic therapy to treat tumors of the extrahepatic biliary ducts : a case report", Arch Surg, 126, pp.111~113 (1991)
16. Ortner ME, "Successful photodynamic therapy for nonresectable cholangiocarcinoma : a randomized prospective study", Gastroenterology, 125, pp.1355~1363 (2003)
17. Kahaleh M, "Unresectable cholangiocarcinoma : comparison of survival in biliary stenting alone versus stenting with photodynamic therapy", Clin Gastroenterol Hepatol, 6, pp.290~297 (2008)
18. Gao F, "Systematic review : photodynamic therapy for unresectable cholangiocarcinoma", J Hepatobiliary Pancreat Sci, 17, pp.125~131 (2010)
19. Moole H, "Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma : a systematic review and meta-analysis", World J Gastroenterol, 23, pp.1278~1288 (2017)
20. Berr F, "Photodynamic therapy for advanced bile duct cancer : evidence for improved palliation and extended survival", Hepatology, 31, pp.291~298 (2000)
21. Dumoulin FL, "Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma", Gastrointest Endosc, 57, pp.860~867 (2003)
22. Wiedmann M, "Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma : 5-year follow-up of a prospective phase II study", Gastrointest Endosc, 60, pp.68~75 (2004)
23. Shim CS, "Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment", Endoscopy, 37, pp.425~433 (2005)
24. Zoepf T, "Palliation of nonresectable bile duct cancer : improved survival after photodynamic therapy", Am J Gastroenterol, 100, pp.2426~2430 (2005)
25. Witzigmann H, "Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma : palliative photodynamic therapy plus stenting is comparable to r1", r2 resection, 2006, pp.244, 230~239
26. Prasad GA, "Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma", Clin Gastroenterol Hepatol, 5, pp.743~748 (2007)
27. Fuks D, "Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice", J Gastroenterol Hepatol, 24, pp.1745~1752 (2009)
28. Quyn AJ, "Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma", HPB(Oxford), 11, pp.570~577 (2009)
29. Gerhardt T, "Combination of bilateral metal stenting and trans-stent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma", Z Gastroenterol, 48, pp.28~32 (2010)
30. Hoblinger A, "Feasibility and safety of long-term photodynamic therapy(PDT)in the palliative treatment of patients with hilar cholangiocarcinoma", Eur J Med Res, 16, pp.391~395 (2011)
31. Cheon YK, "Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma", HPB(Oxford), 14, pp.185~193 (2012)
32. Lee TY, "Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma", World J Gastroenterol, 18, pp.5589~5594 (2012)
33. Pereira SP, "Safety and long term efficacy of porfimer sodium photodynamic therapy in locally advanced biliary tract carcinoma", Photodiagnosis Photodyn Ther, 9, pp.287~292 (2012)
34. Bahng S, "Photodynamic therapy for bile duct invasion of hepatocellular carcinoma", Photochem Photobiol Sci, 12, pp.439~445 (2013)
35. Jayant P. Talreja, "Photodynamic Therapy in Unresectable Cholangiocarcinoma: Not for the Uncommitted", Clinical Endoscopy, 46(4), pp.390~394 (2013), 대한소화기내시경학회
36. 홍미진, "Long-Term Outcome of Photodynamic Therapy with Systemic Chemotherapy Compared to Photodynamic Therapy Alone in Patients with Advanced Hilar Cholangiocarcinoma", Gut and Liver, 8(3), pp.318~323 (2014), 거트앤리버 소화기연관학회협의회
37. Park DH, "Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma", Eur J Cancer, 50, pp.1259~1268 (2014)
38. Strand DS, "ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma", Gastrointest Endosc, 80, pp.794~804 (2014)
39. Hauge T, "Randomised controlled trial of temoporfin photodynamic therapy plus chemotherapy in nonresectable biliary carcinoma : PCS Nordic study", Photodiagnosis Photodyn Ther, 13, pp.330~333 (2016)
40. Wagner A, "Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma : a multicenter prospective phase II study", Hepatology, 62, pp.1456~1465 (2015)
41. Lee TY, "Photodynamic therapy in patients with advanced hilar cholangiocarcinoma : percutaneous cholangioscopic versus peroral transpapillary approach", Photomed Laser Surg, 34, pp.150~156 (2016)
42. Robert Wentrup, "Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma", Gut and Liver, 10(3), pp.470~475 (2016), 거트앤리버 소화기연관학회협의회
43. Yang J, "Treatment of unresectable extrahepatic cholangiocarcinoma using hematoporphyrin photodynamic therapy : a prospective study", Photodiagnosis Photodyn Ther, 16, pp.110~118 (2016)
44. Dolak W, "Photodynamic therapy with polyhematoporphyrin for malignant biliary obstruction : a nationwide retrospective study of 150 consecutive applications", United European Gastroenterol J, 5, pp.104~110 (2017)
45. Pereira SP, "PHOTOSTENT-02 : porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer", ESMO Open, 3, pp.e000379~ (2018)
46. Gonzalez-Carmona MA, "Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma", Aliment Pharmacol Ther, 49, pp.437~447 (2019)
47. Shiryaev AA, "Combined treatment of nonresectable cholangiocarcinoma complicated by obstructive jaundice", Photodiagnosis Photodyn Ther, 26, pp.218~223 (2019)
48. Wu L, "Photodynamic therapy may provide a benefit over systemic chemotherapy among non-surgically managed patients with extrahepatic cholangiocarcinoma", J Surg Oncol (2019)[DOI]
49. Mizandari M, "Percutaneous intraductal radiofrequency ablation is a safe treatment for malignant biliary obstruction : feasibility and early results", Cardiovasc Intervent Radiol, 36, pp.814~819 (2013)
50. Butros SR, "Radiofrequency ablation of intrahepatic cholangiocarcinoma : feasability, local tumor control, and long-term outcome", Clin Imaging, 38, pp.490~494 (2014)
51. Dolak W, "Endoscopic radiofrequency ablation for malignant biliary obstruction : a nationwide retrospective study of 84 consecutive applications", Surg Endosc, 28, pp.854~860 (2014)
52. Tal AO, "Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction", World J Gastrointest Endosc, 6, pp.13~19 (2014)
53. Laquiere A, "Safety and feasibility of endoscopic biliary radiofrequency ablation treatment of extrahepatic cholangiocarcinoma", Surg Endosc, 30, pp.1242~1248 (2016)
54. Wang F, "Endoscopic radiofrequency ablation for malignant biliary strictures", Exp Ther Med, 11, pp.2484~2488 (2016)
55. Wang J, "Percutaneous intraductal radiofrequency ablation combined with biliary stent placement for nonresectable malignant biliary obstruction improves stent patency but not survival", Medicine(Baltimore), 95, pp.e3329~ (2016)
56. Wang Y, "Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma", Oncotarget, 7, pp.53911~53920 (2016)
57. Cui W, "Comparison of intraluminal radiofrequency ablation and stents vs. stents alone in the management of malignant biliary obstruction", Int J Hyperthermia, 33, pp.853~861 (2017)
58. Wu TT, "Percutaneous intraductal radiofrequency ablation for extrahepatic distal cholangiocarcinoma : a method for prolonging stent patency and achieving better functional status and quality of life", Cardiovasc Intervent Radiol, 40, pp.260~269 (2017)
59. Xia N, "Percutaneous intraductal radiofrequency ablation for treatment of biliary stent occlusion : a preliminary result", World J Gastroenterol, 23, pp.1851~1856 (2017)
60. Acu B, "Feasibility and safety of percutaneous transhepatic endobiliary radiofrequency ablation as an adjunct to biliary stenting in malignant biliary obstruction", Diagn Interv Imaging, 99, pp.237~245 (2018)
61. Bokemeyer A, "Endoscopic radiofrequency ablation prolongs survival of patients with unresectable hilar cholangiocellular carcinoma : a case-control study", Sci Rep, 9, pp.13685~ (2019)
62. Hu B, "Initial experience of ERCP-guided radiofrequency ablation as the primary therapy for inoperable ampullary carcinomas", Dig Dis Sci, 65, pp.1453~1459 (2020)
63. Lee YN, "The safety of newly developed automatic temperature-controlled endobiliary radiofrequency ablation system for malignant biliary strictures : a prospective multicenter study", J Gastroenterol Hepatol, 34, pp.1454~1459 (2019)
64. Mohan BP, "Photodynamic therapy(PDT), radiofrequency ablation(RFA)with biliary stents in palliative treatment of unresectable extrahepatic cholangiocarcinoma : a systematic review and meta-analysis", J Clin Gastroenterol, 56, pp.e153~e160 (2022)

관련 논문AI추천